Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Population Pharmacokinetics and Pharmacodynamics of Depemokimab in People with Asthma and Chronic Rhinosinusitis with Nasal Polyps.
Journal: Journal of clinical pharmacology
Published: November 25, 2025
Long-term safety and efficacy of anti-GM-CSF otilimab in patients with rheumatoid arthritis: long-term extension of three phase 3 randomised trials (contRAst X).
Journal: BMJ open
Published: March 05, 2025
Anti-GM-CSF otilimab versus tofacitinib or placebo in patients with active rheumatoid arthritis and an inadequate response to conventional or biologic DMARDs: two phase 3 randomised trials (contRAst 1 and contRAst 2).
Journal: Annals of the rheumatic diseases
Published: May 25, 2023
Anti-GM-CSF otilimab versus sarilumab or placebo in patients with rheumatoid arthritis and inadequate response to targeted therapies: a phase III randomised trial (contRAst 3).
Journal: Annals of the rheumatic diseases
Published: May 18, 2023
A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR).
Journal: The European respiratory journal
Published: July 02, 2021
Targeting GM-CSF in rheumatological conditions: risk of PAP - Authors' reply.
Journal: The Lancet. Rheumatology
Published: March 23, 2021
Efficacy, patient-reported outcomes, and safety of the anti-granulocyte macrophage colony-stimulating factor antibody otilimab (GSK3196165) in patients with rheumatoid arthritis: a randomised, phase 2b, dose-ranging study.
Journal: The Lancet. Rheumatology
Published: December 20, 2019
Anti-granulocyte-macrophage colony-stimulating factor antibody otilimab in patients with hand osteoarthritis: a phase 2a randomised trial.
Journal: The Lancet. Rheumatology
Published: December 20, 2019
MRI of the joint and evaluation of the granulocyte-macrophage colony-stimulating factor-CCL17 axis in patients with rheumatoid arthritis receiving otilimab: a phase 2a randomised mechanistic study.
Journal: The Lancet. Rheumatology
Published: December 20, 2019
Automated Epilepsy Diagnosis Using EEG With Test Set Evaluation.
Journal: IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society
Published: May 07, 2019
Population pharmacokinetics and exposure-response relationship of amatuximab, an anti-mesothelin monoclonal antibody, in patients with malignant pleural mesothelioma and its application in dose selection.
Journal: Cancer chemotherapy and pharmacology
Published: December 14, 2015
Population pharmacokinetic analysis of lenvatinib in healthy subjects and patients with cancer.
Journal: British journal of clinical pharmacology
Published: September 23, 2015
Last Updated: 09/26/2026